Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1803296 | 0.89 | APEX1 (0.38) | HSD17B10LMNAHPGDHIF1AALDH1A1 | |
| SCHEMBL1804101 | 0.89 | APEX1 (0.34) | LCKFYNHSD17B10LMNAALDH1A1 | |
| SCHEMBL1807222 | 0.86 | LCK (0.32) | LCKFYNHSD17B10LMNAHPGD | |
| SCHEMBL1809348 | 0.86 | LCK (0.34) | LCKFYNHSD17B10LMNAHPGD | |
| SCHEMBL1803301 | 0.85 | LCK (0.32) | LCKFYNHSD17B10LMNAHPGD | |
| SCHEMBL1803303 | 0.85 | NT5E (0.34) | LCKFYNHSD17B10LMNAHPGD | |
| SCHEMBL1809351 | 0.82 | LCK (0.34) | LCKFYNHSD17B10LMNAHPGD | |
| SCHEMBL1804879 | 0.81 | ALDH1A1 (0.34) | LCKFYNHSD17B10ING2ALDH1A1 | |
| SCHEMBL1804876 | 0.81 | LCK (0.33) | LCKFYNHSD17B10ING2ALDH1A1 | |
| SCHEMBL5125062 | 0.79 | LCK (0.43) | LCKFYNHSD17B10LMNAING2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | LCK 3120/4885FYN 3062/4885HSD17B10 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.